SNaP Wound Care System Versus Traditional NPWT Device for Treatment of Chronic Wounds
Completed · Not applicable
Conditions studied: Ulcers, Wounds
In brief
The purpose of this study is to evaluate a novel negative pressure wound therapy (NPWT) device called the SNaP device compared to a traditional NPWT device for the treatment of lower extremity diabetic and venous ulcer wounds.
Key facts
- Study ID
- NCT00951080
- Run by
- 3M
- People needed
- 132
- Starts
- 2009-07-01
- Expected to finish
- 2011-03-01
- Last updated by the study team
- 2022-08-01
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subject has Venous Ulcer or Diabetic Ulcer with a surface area < 100 sq. cm and < 10 cm in widest diameter on lower extremity, but larger than 1 sq. cm
- Subject has wound present for >30 days despite appropriate wound care
- Subject has adequate blood perfusion (Defined as either transcutaneous oxygen measurements of the dorsum of the foot >30 mmHg or 0.7 < ABI <1.2)
- Subject has wound in location amendable to creation of airtight seal around wound using NPWT dressings
- Subject is able to understand and provide written consent
- Subject able to understand and provide written consent
- Male or non-pregnant female willing to have urine pregnancy test
You may not qualify if…
- Subject has Active Infection (Redness, Swelling, Pain, Purulent Exudate)
- Subject has Untreated Osteomyelitis
- Subject has Allergy to Wound Care Products used in the study
- Subject has Malignancy, Burn, Collagen Vascular Disease, Sickle Cell, Vasculopathy, or Pyoderma Gangrenosum Origin of Wound
- Subject has Active Charcot Arthropathy of the Foot
- Subject has study wound location on toes or plantar surface of foot
- Subject has uncontrolled hyperglycemia (HbA1C >12%)
- Subject has end stage renal disease requiring dialysis
- Subject is undergoing active chemotherapy treatment that inhibits wound healing
- Subject has had previous treatment with NPWT device, growth factors, hyperbaric oxygen, or bioengineered tissue product within 30 days of enrollment
- Subject has a >30% wound surface area reduction in size at 1 week after screening visit
- Subject has any other condition that, in the opinion of the investigator, makes the subject inappropriate to take part in this study
- Subject is unwilling or unable to comply with protocol requirements
- Subject is pregnant
Where it is running
- Hope Research Institute — Phoenix, Arizona, United States
- Southern Arizona Limb Salvage Alliance (SALSA) — Tucson, Arizona, United States
- Center for Clinical Research, Inc. — Castro Valley, California, United States
- Jay Mukker, DPM Inc. — Fresno, California, United States
- Palomar Pomerado Health Wound Care Center — Poway, California, United States
- O'Connor Wound Care Clinic — San Jose, California, United States
- John Muir Wound Care Center — Walnut Creek, California, United States
- Georgetown University Hospital — Washington D.C., District of Columbia, United States
- Bethesda Health City Wound Care Center — Boynton Beach, Florida, United States
- Wound Care on Wheels, LLC — Jacksonville, Florida, United States
- Osceola Regional Medical Center — Kissimmee, Florida, United States
- Weil Foot & Ankle Institute — Des Plaines, Illinois, United States
- LA Cardiovascular & Limb Salvage Center — Lafayette, Louisiana, United States
- University of North Carolina — Chapel Hill, North Carolina, United States
- The Christ Hospital, Wound Healing Center — Cincinnati, Ohio, United States
- New Bridge Medical Research Corporation — Warren, Pennsylvania, United States
- Southwest Washington Medical Center Wound Healing Center — Vancouver, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.